[¶ 1] The State of North Dakota, through Williams County Assistant State’s Attorney Nathan Kirke Madden, petitions this Court for a supervisory writ directing the district court to vacate a pretrial order requiring the State to produce the Director of the State Crime Laboratory at trial in the prosecution of James Christian-son for driving while under the influence of alcohol. The State argues thé district court misinterpreted N.D.R.Ev. 707 to require the State to produce the Director for Christianson’s criminal trial. We exercise our supervisory jurisdiction and direct the district court to vacate its order, concluding this record does not establish the Director made any testimonial statements in an analytical report assessing Christian-son’s blood-alcohol content.
I
[¶ 2] Christianson was arrested for driving while under the influence of alcohol and submitted to a blood draw at a Willi-ston hospital. The analytical report from the blood draw showed Christianson’s blood-alcohol content was above the legal limit, and the State charged him with driving or being in actual physical control of a motor vehicle while under the influence of alcohol, or with a blood alcohol content above the legal limit. The State notified Christianson under N.D.R.Ev. 707(a) that it intended to introduce into evidence at trial the analytical report from his blood test, which had been certified by a forensic scientist at the State Crime Laboratory, Roberta Grieger-Nimmo. Christianson objected to the introduction of the analytical report under N.D.R.Ev. 707(b) and identified four witnesses to be produced at trial to testify about the.report, including the specimen collector, the analyst, and the Director of the State Crime Laboratory. The State thereafter moved to allow the introduction of the analytical report without the testimony of the Director, Hope Olson.
[¶ 3] In a decision rendered before this Court’s decisions in State ex rel. Roseland v. Herauf,
First of all, with regard to the State’s Motion for Admissibility of Lab Results Without the Testimony of Hope Olson, it is important to note that the cases cited by the State, Melendez-Diaz v. Massachusetts,557 U.S. 305 , 326-327 [129 S.Ct. 2527 ,174 L.Ed.2d 314 ] (2009) and State v. Gietzen,2010 ND 8 [ ]2,786 N.W.2d 1 , both predate North Dakota Rules of Evidence 707, which was adopted effective February 1, 2010, and amended March 1, 2011. While the Gietzen case was filed May 11, 2010, and modified June 30, 2010, trial was held on October 14, 2009, and that decision made no reference to, and did not rely on, Rule 707 in rendering its decision. As such, the Court has not been directed to any cases addressing the issue.
II
[¶ 4] The State petitions this Court to exercise its original jurisdiction and issue a supervisory writ, arguing it is not required to produce Olson at trial because she made no testimonial statements in the analytical report and it has no alternative remedy available to address the district court’s interpretation of N.D.R.Ev. 707.
[¶ 5] Under N.D. Const, art. VI, § 2, and N.D.C.C. § 27-02-04, we may review a district court decision under our supervisory authority. Herauf,
[¶ 6] We conclude this is an appropriate case to exercise our supervisory jurisdiction because the State lacks another adequate remedy. The State’s ability to appeal is limited under N.D.C.C. § 29-28-07. If Christianson were found not guilty by a jury, the State could not appeal. See State v. Bernsdorf,
[¶ 7] The North Dakota Association of Criminal Defense Lawyers, as amicus curiae, argue this is not an extraordinary case necessary to rectify an error or prevent an injustice and the State has at least two adequate alternative remedies. The Association of Criminal Defense Lawyers argues the State can either produce the Director at trial, or depose her and offer her deposition in lieu of her testimony. Both alternatives require the State to comply with the district court order and, seemingly, reserve any challenge to the order for appeal. However, as we explained above, the State would likely not be able to raise the issue on appeal, making the proposed remedies inadequate. We therefore conclude this is an appropriate case to exercise our supervisory jurisdiction.
Ill
[¶ 8] The State argues the district court misinterpreted N.D.R.Ev. 707 to require the State to produce the Director at trial, because the State claims the Director had no part in the analysis of Christian-son’s blood sample and made no testimonial statements in the analytical report. The
[¶ 9] The issue in this case involves the admissibility of the analytical report in the context of N.D.R.Ev. 707, N.D.C.C. § 39-20-07, and the Confrontation Clause of the Sixth Amendment of the United States Constitution. The Confrontation Clause, made applicable to the States under the Fourteenth Amendment, Pointer v. Texas,
[¶ 10] In Crawford v. Washington,
Various formulations of this core class of “testimonial” statements exist: “ex parte in-court testimony or its functional equivalent — that is, material such as affidavits, custodial examinations, prior testimony that the defendant was unable to cross-examine, or similar pretrial statements that declarants would reasonably expect to be used prosecuto-rially”; “extrajudicial statements ... contained in formalized testimonial materials, such as affidavits, depositions, prior testimony, or confessions”; “statements that were made under circumstances which would lead an objective witness reasonably to believe that the statement would be available for use at a later trial[.]”
Crawford, at 51-52,
[¶ 11] In Melendez-Diaz v. Massachusetts,
Contrary to the dissent’s suggestion, ... we do not hold, and it is not the ease, that anyone whose testimony may be relevant in establishing the chain of custody, authenticity of the sample, or accuracy of the testing device, must appear in person as part of the prosecution’s ease. While the dissent is correct that “[i]t is the obligation of the prosecution to establish the chain of custody,” ... this does not mean that everyone who laid hands on the evidence must be called.
Id. at 311, n. 1,
[¶ 12] In Bullcoming v. New Mexico, — U.S. -,
[¶ 13] Rule 707, N.D.R.Ev., was adopted effective February 1, 2010, to address confrontation issues involving the admissibility of analytical reports in North Dakota courts in response to Melendez-Diaz. See N.D.R.Ev. 707, Explanatory Note and Sources. Rule 707, ND.R.Ev., provides in part:
(a) Notification to Defendant. If the prosecution intends to introduce an analytical report issued under N.D.C.C. chs. 19-03.1, 19-03.2, 19-03.4, 20.1-13.1, 20.1-15, 39-06.2, or 39-20 in a criminal trial, it must notify the defendant or the defendant’s attorney in writing of its intent to introduce the report and must also serve a copy of the report on the defendant or the defendant’s attorney at least 30 days before the trial.
(b) Objection. At least 14 days before the trial, the defendant may object in writing to the introduction of the report and identify the name or job title of the witness to be produced to testify about the report at trial. If objection is made, the prosecutor must produce the person requested. If the witness is not available to testify, the court must grant a continuance.
(c) Waiver. If the defendant does not timely object to the introduction of the report, the defendant’s right to confront the person who prepared the report is waived.
[¶ 14] In Herauf,
under the statute, a prerequisite to admission of an analytical report is a signed statement from the individual medically qualified to draw the blood sample that the blood sample was properly drawn. N.D.C.C. § 39-20-07(5) and (10); Schlosser [v. N.D. Dept, of Transp.J,2009 ND 173 , ¶9,775 N.W.2d 695 . Section 39-20-07(10), N.D.C.C., provides: “[a] signed statement from the individual medically qualified to draw the blood sample for testing as set forth in [N.D.C.C. § 39-20-07] subsection 5 is prima facie evidence that the blood sample was properly drawn[.]” Rather than a foundational requirement, see State v. Gietzen,2010 ND 82 , ¶¶ 16-19,786 N.W.2d 1 , State v. Friedt,2007 ND 108 , ¶¶ 7, 10-11, 13,735 N.W.2d 848 , we conclude the “signed statement” contemplated under N.D.C.C. § 39-20-07(10) constitutes a testimonial statement. The signed statement is akin to an affidavit, which is testimonial, see Crawford,541 U.S. at 51-52 [,124 S.Ct. 1354 ], because it is a “solemn declaration or affirmation made for the purpose of establishing or proving” that the blood sample was properly obtained. Melendez-Diaz,129 S.Ct. at 2532 (quoting Crawford,541 U.S. at 51 [124 S.Ct. 1354 ]). The fact that the signed statement is unsworn is not dis-positive in determining if the statement is testimonial. Bullcoming,131 S.Ct. at 2717 . Also, as in Melendez-Diaz, the sole purpose of the signed statement in subsection 10 is to establish prima facie evidence that the blood sample was properly drawn. N.D.C.C. § 39-20-07(10); see Melendez-Diaz, 129 S.Ct. at 2532 .
Herauf, at ¶ 14. In Herauf, at ¶ 15, the majority concluded “N.D.R.Ev. 707, when construed with N.D.C.C. § 39-20-07 and the constitutional rights it provides, requires the State to produce the individual who drew the defendant’s blood sample if the defendant objects under N.D.R.Ev. 707(b) and identifies the individual who drew the defendant’s blood as a witness to be produced at trial.”
[¶ 15] In Lutz,
[¶ 16] In Herauf and Lutz, we construed N.D.R.Ev. 707 in conjunction with the evidentiary shortcuts authorized under N.D.C.C. § 39-20-07 and the rights protected by the Confrontation Clause and held an accused may require the State to produce at trial witnesses who make testimonial statements in the prima facie evidence authorized under the evidentiary shortcuts, including the analytical reports and the statement signed by a medically qualified blood drawer. In Herauf and Lutz, the substance of those statements were prepared for a prima facie evidentia-ry purpose and were testimonial.
[¶ 17] This record does not establish the Director conducted the blood analysis or otherwise participated in any manner in the analysis. Although the Director’s job title is mentioned in forensic scientist Grieger-Nimmo’s certification to the extent Grieger-Nimmo is a “designee” of the Director, nothing in the certification or analytical report constitutes a testimonial statement by the Director for confrontation purposes. There is no statutory language like the language in N.D.C.C. § 39-20-07(10), which requires the Director to make testimonial statements in the prima facie evidence established under the evi-dentiary shortcuts in N.D.C.C. § 39-20-07. Nothing in the Director’s expected testimony would prove the substance of the results of the analytical report, or that the blood sample was properly drawn. Under Herauf and Lutz in conjunction with N.D.R.Ev. 707 and the evidentiary shortcuts authorized by N.D.C.C. § 39-20-07, the State is not required to provide the Director as a witness at trial to satisfy the Confrontation Clause because this record does not establish the Director conducted or otherwise participated in the blood analysis or made any testimonial statements in analytical reports.
[¶ 19] We conclude the district court’s interpretation of N.D.R.Ev. 707(b) that any requested witness “must” be produced at trial is too broad. The State need not produce designated persons for confrontation purposes if those persons do not make testimonial statements in analytical reports. See Lutz,
IV
[¶ 20] We exercise our supervisory jurisdiction and direct the district court to vacate its order.
